Registry for young adults diagnosed with pancreatic cancer
Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer
Azienda Ospedaliera Universitaria Integrata Verona · NCT05845801
This study is gathering information from young adults diagnosed with pancreatic cancer to help improve future treatments and understand how this disease affects them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years to 55 Years |
| Sex | All |
| Sponsor | Azienda Ospedaliera Universitaria Integrata Verona (other) |
| Locations | 1 site (Verona) |
| Trial ID | NCT05845801 on ClinicalTrials.gov |
What this trial studies
This registry aims to collect clinical, pathological, and genomic data, along with survival outcomes, from individuals diagnosed with pancreatic ductal adenocarcinoma (PDAC) at or before the age of 55. By gathering this information, the registry seeks to facilitate future clinical trials that can utilize both prospective and retrospective data. The focus is on understanding the unique characteristics and outcomes of younger patients with this aggressive cancer.
Who should consider this trial
Good fit: Ideal candidates for this registry are individuals aged 18 to 55 who have been diagnosed with pancreatic cancer.
Not a fit: Patients diagnosed with pancreatic neoplasms other than pancreatic cancer or those outside the age criteria will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of pancreatic cancer in young adults and inform future treatment strategies.
How similar studies have performed: While registries for pancreatic cancer exist, this specific focus on young adults is relatively novel and may provide unique insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≤55 years old at the time of diagnosis of pancreatic cancer * Age ≥ 18 years * Written informed consent obtained. Exclusion Criteria: * Any pancreatic neoplasm other than pancreatic cancer (e.g. cholangiocarcinoma, ampullary cancer,duodenal cancer, non-invasive mucinous cystic neoplasm, pancreatic intra-epithelial neoplasia 1 and 2, non-invasive intraductal papillary mucinous neoplasm, serous cystic neoplasm, pseudo papillary solid tumor, neuroendocrine tumor) * Absence of informed consent. * Age \< 18 years or \> 55 years old at the time of diagnosis of pancreatic cancer
Where this trial is running
Verona
- AOUI Verona — Verona, Italy (RECRUITING)
Study contacts
- Study coordinator: Fabio Casciani
- Email: fabio.casciani@univr.it
- Phone: 0458124671
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: PDAC - Pancreatic Ductal Adenocarcinoma